Vaccinex annual capital expenditures (capex)
2017
2018
2019
2020
2021
2022
2023
2024
Vaccinex Capital Expenditures (CapEx) Growth & History (VCNX)
Vaccinex's capital expenditures (capex) was $22,000 for fiscal 2024.
View full Vaccinex company overviewVaccinex annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $22,000 | −$45,000 | −67.16% |
| 2023 | 2023-12-31 | $67,000 | −$32,000 | −32.32% |
| 2022 | 2022-12-31 | $99,000 | $67,000 | +209.38% |
| 2021 | 2021-12-31 | $32,000 | −$258,000 | −88.97% |
| 2020 | 2020-12-31 | $290,000 | $212,000 | +271.79% |
| 2019 | 2019-12-31 | $78,000 | −$157,000 | −66.81% |
| 2018 | 2018-12-31 | $235,000 | $167,000 | +245.59% |
| 2017 | 2017-12-31 | $68,000 | — | — |
Vaccinex quarterly capital expenditures (capex)
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q3.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $8,000 | −$10,000 | −55.56% |
| Q2 2024 | 2024-06-30 | $14,000 | $14,000 | — |
| Q1 2024 | 2024-03-31 | $0 | −$49,000 | — |
| Q4 2023 | 2023-12-31 | $0 | — | — |
| Q3 2023 | 2023-09-30 | $18,000 | −$31,000 | −63.27% |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $49,000 | — | — |
| Q3 2022 | 2022-09-30 | $49,000 | $39,000 | +390.00% |
| Q3 2021 | 2021-09-30 | $10,000 | −$27,000 | −72.97% |
| Q4 2020 | 2020-12-31 | $1,000 | — | — |
| Q3 2020 | 2020-09-30 | $37,000 | $27,000 | +270.00% |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $254,000 | — | — |
| Q3 2019 | 2019-09-30 | $10,000 | $5,000 | +100.00% |
| Q4 2018 | 2018-12-31 | $169,000 | — | — |
| Q3 2018 | 2018-09-30 | $5,000 | −$3,000 | −37.50% |
| Q2 2018 | 2018-06-30 | $14,000 | — | — |
| Q1 2018 | 2018-03-31 | $47,000 | — | — |
| Q3 2017 | 2017-09-30 | $8,000 | — | — |
Vaccinex capital expenditures (capex) trends
Over the last five fiscal years, Vaccinex's capital expenditures (capex) decreased from $78,000 to $22,000, a change of −$56,000. The latest reported quarter, Q4 2024, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗